Lung

Type of Cancer: NSCLC

Sponsor: BMS

Phase / Design: Phase 3 Randomized Open label

Population: Locally advanced: Stage IIIA, IIIB, or IIIC Unresectable Amenable to Chemoradiotherapy Naïve EGFR mutation (-)

Breast
Lung
Menu